N of 1 randomised controlled trials of oral ketamine in patients with chronic pain
- 1 November 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Pain
- Vol. 83 (2) , 283-287
- https://doi.org/10.1016/s0304-3959(99)00117-7
Abstract
Anecdotal reports suggest that the general anaesthetic drug ketamine, taken orally in low doses, can give rise to some extra analgesia in patients with refractory neuropathic pain. This study was designed to determine the proportion of patients with chronic neuropathic pain responding to oraKeywords
This publication has 12 references indexed in Scilit:
- Ketamine Injection Used OrallyPalliative Medicine, 1996
- Interaction of the Chiral Forms of Ketamine with Opioid, Phencyclidine, σ and Muscarinic ReceptorsBasic & Clinical Pharmacology & Toxicology, 1995
- Continuous subcutaneous administration of the N -methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgiaPain, 1995
- The Role of Ketamine, an NMDA Receptor Antagonist, in the Management of PainProgress in Palliative Care, 1995
- Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 designPain, 1994
- Successful Treatment of Postherpetic Neuralgia with Oral KetamineThe Clinical Journal of Pain, 1994
- Relief of post-herpetic neuralgia with the Symbol receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placeboPain, 1994
- Response of chronic neuropathic pain syndromes to ketamine: a preliminary studyPain, 1994
- The n-of-1 Randomized Controlled Trial: Clinical UsefulnessAnnals of Internal Medicine, 1990
- PHARMACOKINETICS AND ANALGESIC EFFECTS OF I.M. AND ORAL KETAMINEBritish Journal of Anaesthesia, 1981